SEC Form 4 · accession 0001209191-15-003501
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mayflower L.P.
10% Owner
Period of report
Jan 8, 2015
Accepted (ET)
Jan 9, 2015 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F3 | Jan 8, 2015 | S$0 | 57,673 | — | D | 1,789,719 | I | See Footnote |
| Class A Common StockF2,F3 | Jan 9, 2015 | S$0 | 61,971 | — | D | 1,727,748 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold in multiple transactions at a weighted average price of $30.2034 per share at prices ranging from $29.83 to $30.44. The reporting persons undertake to provide Phibro Animal Health Corp (the "Issuer"), any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F2Shares were sold in multiple transactions at a weighted average price of $30.157 per share at prices ranging from $29.90 to $30.39. The reporting persons undertake to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3Shares are directly held by Mayflower LP ("Mayflower"). Investment and divestment decisions with respect to the shares held by Mayflower are made by the investment committee of 3i Investments plc, which is the manager of Mayflower. 3i Investments plc is an indirect wholly owned subsidiary of 3i Group plc, a public company listed on the London Stock Exchange. 3i Investments plc is advised by 3i Corporation, which is also an indirect wholly owned subsidiary of 3i Group plc.